An unusual case of ascites: Pitfalls in diagnosis of malignant peritoneal mesothelioma

Australian and New Zealand Journal of Surgery

Volumn 70, Issue 5, 2000, Pages 384-388

  Clark, J R ^a,b   Ross, W B ^a  

^a ST GEORGE HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Asbestos; Laparoscopy; Mesothelioma; Peritoneal malignancy

Indexed keywords

ADULT; ARTICLE; ASCITES; CANCER DIAGNOSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; HUMAN; LAPAROSCOPY; MALE; PERITONEUM MESOTHELIOMA;

ADENOMA, VILLOUS; ASCITES; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; FIBROSIS; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OMENTUM; PERITONEAL NEOPLASMS; PERITONEUM;

EID: 0034112406     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2000.01834.x     Document Type: Article

References (86)

1. Aseno JA, Goldblatt P, Thomford NR. Primary malignant peritoneal mesothelioma. Arch. Surg. 1990; 125: 1477-81.
2. Clement PB, Young RH, Scully RE. Malignant mesotheliomas presenting as ovarian masses. A report of nine cases including two ovarian mesotheliomas. Am. J. Surg. Pathol. 1996; 20: 1067-80.
3. Plaus WJ. Peritoneal mesothelioma. Arch. Surg. 1988; 123: 763-6.
4. Norman PE, Vhittaker D. Nine-year survival in a case of untreated peritoneal mesothelioma. Med. J. Aust. 1989; 150: 43-4.
5. Piccigallo E, Jeffers LJ, Reddy KR et al. Malignant peritoneal mesothelioma. A clinical and laparoscopic study of ten cases. Dig. Dis. Sei. 1988; 33: 633-9.
6. Brenner J, Sordillo PP, Magill GB. Seventeen-year survival in a patient with malignant peritoneal mesothelioma. Clin. Oncol. 1981; 7: 249-51.
7. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997; 30: 403-18.
8. Peto J, Hogdson JT, Matthews FE, Jones Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 535-9.
9. Reuter K, Raptopoulos V, Reale F et al. Diagnosis of peritoneal mesothelioma: Computerised tomography, sonography, and fine-needle aspiration biopsy. AJR 1983; 140: 1189-94.
10. van der Harst E, van Dongen EH, Viergever PP, Meijer WW. Peritoneal mesothelioma without ascites formation. Scand. J. Gastroenterol. 1993; 28: 190-2.
11. Driscoll TR, Baker GJ, Daniels S et al. Clinical aspects of malignant mesothelioma in Australia. Aust. N.Z. J. Med. 1993; 23: 19-25.
12. Ros PR, Yuschok TJ, Buck JL et al. Peritoneal mesothelioma. Radiological appearances correlated with histology. Acta Radial. 1991; 32: 355-8.
13. van Gelder T, Hoogsteden HC, Vernel MA et al. Malignant peritoneal mesothelioma: A series of 19 cases. Digestion 1989; 43: 222-7.
14. Raptopoulos V. Peritoneal mesothelioma. Crit. Rev. Diagn. Imaging 1985; 24: 293-328.
15. Soulie P, Ruffie P, Trandafir L et al. Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-study of weekly cisplatin/ interferon alpha-2a. J. Clin. Oncol. 1996; 14: 878-85.
16. Miller J, Wynn H. A malignant tumour arising from the endothelium of the peritoneum and producing a mucoid ascitic fluid. J. Pathol. Bacterial. 1908; 12: 267.
17. Leigh J, Corvalan CF, Grimwood A et al. The incidence of malignant mesothelioma in Australia 1982-88. Am. J. Ind. Med. 1991; 20: 643-55.
18. Asensio JA, Goldblatt P, Thomford NR. Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature. Arch. Surg. 1990; 125: 1477-81.
19. Watteeuw G, D'Hondt A, Tannouri F et al. Malignant peritoneal mesothelioma. Case report and review of the literature. Acta Clin. Belg. 1995; 50: 222-6.
20. Musk AW, Dolan PJ, Armstrong BK et al. The incidence of malignant mesothelioma in Australia, 1947-80. Med. J. Aitst. 1989; 150: 242-3,246.
21. Lee J, Rogers AJ, Ferguson DA. Lung asbestos fibre content and mesothelioma cell type, site, and survival. Cancer 1991; 68: 135-41.
22. Roggli VL, Oury TD, Moffatt EJ. Malignant mesothelioma in women. Anat. Pathol. 1997; 2: 147-63.
23. deKlerk NH, Armstrong BK, Musk AW, Hobbs MS. Predictions of further cases of asbestos-related disease among former miners and millers of crociodolite in Western Australia. Med. J. Aust. 1989; 151: 616-20.
24. Coggin D, Inskip H, Winter P, Pannet B. Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis. Occup. Environ. Med. 1995; 52: 775-7.
25. Roggli VL. Malignant mesothelioma and duration of asbestos exposure: Correlation with tissue mineral fibre content. Ann. Occup. Hyg. 1995; 39: 373-4.
26. Browne K, Simther WJ. Asbestos-related mesothelioma: Factors discriminating between pleural and peritoneal sites. Br. J. Ind. Med. 1983; 40: 145-52.
27. Armstrong BK, Musk AW, Baker JE et al. Epidemiology of malignant mesothelioma in Western Australia. Med. J. Aust. 1984; 141: 86-8.
28. Baris B, Demir AU, Shehu V et al. Environmental fibrous zeolite (eronite) exposure and malignant tumours other than mesothelioma. J. Environ. Pathol. Toxicol. Oncol. 1996; 15: 183-9.
29. Ferguson D. Malignant mesothelioma: The rising epidemic. Med. J. Aust. 1989; 150: 233-5.
30. Price B. Analysis of current trends in United States mesothelioma incidence. Am. J. Epidemiol. 1997; 145: 211-18.
31. Volgelzang NJ. Malignant mesothelioma: Diagnostic and management strategies for 1992. Semin. Oncol 1992; 19 (Suppl. 11): 64-71.
32. Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant peritoneal mesothelioma: Review of 25 patients. Am. J. Gastroenterol. 1981; 75: 311-13.
33. Anderson JH, Stewart CJ, Hanseil DT, Anderson Peritoneal mesothelioma. Postgrad. Afed. J. 1990; 66: 866-8.
34. Wagner JC, Sleegs ÇA, Marchand P. Diffuse pleural mesothelioma. Br. J. Ind. Med. 1960; 17: 260-71.
35. Tamir G, Sandbank J, Rubin M, Antebi E. Malignant peritoneal mesothelioma. Harefuah 1993; 124: 613-16, 667.
36. Manavoglu O, Orhan B, Evensel T et al. Malignant peritoneal mesothelioma following asbestos exposure. J. Environ. Pathol. Toxicol. Oncol. 1996; 15: 191-4.
37. Moltoni C, Pinto C, Carnuccio R et al. Mesotheliomas following exposure to asbestos used in railroads. Mcd. Lav. 1995; 86: 461-77.
38. Spirtas R, Heineman EF, Bernstein L el al. Malignant mesothelioma: Attributable risk of asbestos exposure. Occup. Environ. Med. 1994; 51: 804-11.
39. Bianchi C, Brollo A, Ramani L, Zuch C. Asbestos-related mesothelioma in Monfalcone, Italy. Am. J. Ind. Med. 1993; 24: 149-60.
40. Suzuki Y. Diagnostic criteria for human diffuse mesothelioma. Acta Palhol. Jpn 1992; 42: 767-86.
41. Almudevar Bercero E, Garcia-Rostan Ferez GM, Garcia Bragado F et al. Prognostic value of high serum levels of CA-125 in malignant secretory peritoneal mesotheliomas affecting young women. Histopaihology 1997; 31: 267-73.
42. Smith TR. Malignant peritoneal mesothelioma: Marked variability of CT findings. Abdom. Imaging 1994; 19: 27-9.
43. Tassile D, Roth AD, Kurt AM et al. Colon cancers and peritoneal mesothelioma occurring 29 years after abdominal radiation for testicular seminoma. A case report and review of the literature. Oncology 1998; 55: 289-92.
44. Gilks B, Hegedus C, Freeman H et al. Malignant peritoneal mesothelioma after remote abdominal radiation. Cancer 1998; 61: 2019-21.
45. Weissmann LB, Corson JM, Neugut AI, Antman KH. Malignant mesothelioma following treatment for Hodskin's disease. J. Clin. Oncol. 1996; 14: 2098-100.
46. Horie A, Hiraoka K, Yamamoto O et al. An autopsy case of peritoneal mesothelioma in a radiation technologist. Acta Palhol. Jpn 1990; 40: 57-62.
47. Maurer R, Egloff B. Malignant peritoneal mesothelioma after cholangiography with thorotrast. Cancer 1975; 36: 1381-5.
48. Stey C, Landolt-Weber U, Vetter W et al. Malignant peritoneal mesothelioma after Thorotrast exposure. Am. J. Clin. Oncol. 1995; 18: 313-17.
49. Riddel RH, Goodman MJ, Moossa AR. Peritoneal malignant mesothelioma in a patient with recurrent peritonitis. Cancer 1981; 48: 134-9.
50. Dawson A, Gibbs AR, Pooley FD et al. Malignant mesothelioma in women. Thorax 1993; 48: 269-74.
51. Enterline PE, Hartley J, Henderson V. Asbestos and cancer: A cohort followed up to death. Br. J. Ind. Med. 1987; 44: 396-401.
52. Goldblum J, Hart WR. Localised and diffuse mesotheliomas of the genital tract and peritoneum in women. Am. J. Snrg. Patlwl. 1995; 19: 1124-37.
53. Steffen HM, Warmbach G, Hoffmann A et al. Diagnosis and therapy of malignant peritoneal mesothelioma. Med. Klin. 1989;84:469-73.
54. Chachati A, Hoyoux P, Smoliar V. Peritoneal mesothelioma: Case report and review of the literature. Acta Clin. Belg. 1984; 39: 141-7.
55. Duan HJ, Itoh N, Yamagami T et al. Diffuse malignant peritoneal mesothelioma in a young woman with a high serum level of CA-125. Acta Patlwl. Jpn 1991; 41: 158-63.
56. Simsek H, Kadayifci A, Okan E. Importance of serum CA 125 levels in malignant peritoneal mesothelioma. Tumour Biol. 1996; 17: 1-4.
57. Averbach AM, Sugarbaker PH. Peritoneal mesothelioma: Treatment approach based on natural history. Cancer Treat. Res. 1996; 81: 193-211.
58. Guest PJ, Reznek RH, Selleslag D et al. Peritoneal mesothelioma: The role of computed tomography in diagnosis and follow-up. Clin. Radial. 1992; 45: 79-84.
59. Andrion A, Feyles E, Zai G et al. Malignant peritoneal mesothelioma mimicking mesenteric inflammatory disease. Patlwl. Res. Pract. 1994; 190: 615-22.
60. Whitley NO, Brenner DE, Antman KH et al. CT of peritoneal mesothelioma: Analysis of eight cases. AJR 1982; 138:531-5.
61. Gupta S, Gupta RK, Gujral RB et al. Peritoneal mesothelioma simulating pseudomyxoma peritonei on CT and sonography. Gastroinfest. Radial. 1992; 17: 129-31.
62. Pombo F, Rodriguez E, Martin R, Lago M. CT-guided core-needle biopsy in omental pathology. Acta Radial. 1997; 38: 978-81.
63. McCallum RW, Maceri DR, Jensen D, Berci G. Laparoscopic diagnosis of peritoneal mesothelioma. Report of a case and review of the diagnostic approach. Dig. Dis. Sei. 1979; 24: 170-4.
64. Brenner DE, Whitley NO, Goldstein WZ, Aisner J. Computed tomographic demonstration of peritoneal mesothelioma. Lancet 1981; 1:939-10.
65. Gonzalez-reimers E, Gomez MA, Santolaria-Fernandez F et ai. Tc-99m HMDP accumulation in primary peritoneal mesothelioma. Clin. Niicl. Mecl. 1992; 17: 738-9.
66. Armas RR, Goldsmith SJ. Gallium scanning in peritoneal mesothelioma. AJR 1985; 144: 563-5.
67. Dach J, Patel N, Patel S, Petasnick J. Peritoneal mesothelioma: CT, sonography and gallium-67 scan. AJR 1980; 135: 614-16.
68. Conlon KC, Rusch VW, Gillern S. Laparoscopy: An important tool in the staging of peritoneal mesothelioma. Ann. Sitrg. Oncol. 1996; 3: 489-94.
69. Estrada Saiz RV, Loscos Valerio JM, Garcia-Paredes J et al. The role of laparoscopy in the diagnosis of primary peritoneal mesothelioma. Rev. Esp. Enferm. Dig. 1995; 87: 403-6.
70. Chu CM, Lin SM, Peng SM et al. The role of laparoscopy in the evaluation of ascites of unknown origin. Gastrointest. Enclose. 1994:40:285-9.
71. Muensterer OJ, Averbach AM, Jacquet P et al. Malignant peritoneal mesothelioma. Case report demonstrating pitfalls of diagnostic laparoscopy. Int. Surg. 1997; 82: 240-3.
72. Whitwell F, Rawcliffe RM. Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax 1971; 26: 6-22.
73. Sridhar KS, Doria R, Raub Jr WA et al. New strategies are needed in diffuse malignant mesothelioma. Cancer 1992; 70: 2969-79.
74. Weidner N. Malignant mesothelioma of peritoneum. Ultrastnict. Patlwl. 1991; 15: 515-20.
75. Mezger J, Lamerz R, Permantter W. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. J. Tliorac. Cardiovasc. Surg. 1990; 100: 860-6.
76. Eyden BP, Banik S, Harris M. Malignant epithelial mesothelioma of the peritoneum: Observations on a problem case. Ultrastruct. Pathol. 1996; 20: 337-14.
77. Jatzko GR, Jester J. Simultaneous occurrence of a rectal carcinoma and a diffuse well differentiated papillary mesothelioma of the peritoneum. Int. J. Colorectal Dis. 1997; 12: 326-8.
78. Antman KH, Osteen RT, Klegar KL et al. Early peritoneal mesothelioma: A treatable malignancy. Lancet 1985; 2: 977-81.
79. Tsavaris N, Primikirios N, Mylonakis N et al. Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study. Anticancer Res. 1997; 17: 3799-802.
80. Lederman GS, Recht A, Herman T et al. Long term survival in peritoneal mesothelioma: The role of radiotherapy and combined modality treatment. Cancer 1987; 59: 1882-6.
81. Lederman GS, Recht A, Herman T et al. Combined modality treatment of peritoneal mesotheliomas. Monogr. Natl Cancer Inst. 1988; 6: 321-2.
82. Tani M, Tanimura H, Yamaue H et al. Successful immunochemotherapy for patients with malignant mesothelioma: Report of two cases. Surg. Today 1998; 28: 647-51.
83. Westermann AM, Dubbelman R, Moolenaar WH et al. Successful intraperitoneal sumarin treatment of peritoneal mesothelioma. Ann. Oncol. 1997; 8: 801-2.
84. Chen MY, Chiles C, Loggie BW et al. Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J. Surg. Oncol. 1997; 66: 19-23.
85. Newhouse ML, Berry G, Wagner G et al. Mortality of factory workers in East London. Br. J. Ind. Med. 1985; 42: 4-11.
86. Selikoff IJ, Hammond EC, Seidman H. Mortality experience of insulation workers in the US and Canada. Ann. N.Y. Acad. Sei. 1979; 330: 91-116.